Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas

Soft tissue sarcomas (STS), including rhabdomyosarcoma (RMS), exhibit significant heterogeneity and limited responsiveness to immune checkpoint blockade (ICB). Unsupervised tumor immune phenotype based on multi-omics expression profiling of STS has been less studied. To reveal the tumor immune pheno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rong, Chao (VerfasserIn) , Liu, Yun (VerfasserIn) , Xiang, Fang (VerfasserIn) , Zhao, Xin (VerfasserIn) , Zhang, Jinjin (VerfasserIn) , Xiao, Zuorun (VerfasserIn) , Wang, Jinsha (VerfasserIn) , Chen, Lin (VerfasserIn) , Guo, Zhiqi (VerfasserIn) , Zhang, Ziyu (VerfasserIn) , An, Jingnan (VerfasserIn) , Shen, Jing (VerfasserIn) , Heß, Jochen (VerfasserIn) , Yuan, Xiaodong (VerfasserIn) , Zhang, Qiong (VerfasserIn) , Wang, Shouli (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 01 August 2025
In: npj precision oncology
Year: 2025, Jahrgang: 9, Pages: 1-14
ISSN:2397-768X
DOI:10.1038/s41698-025-01064-8
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41698-025-01064-8
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41698-025-01064-8
Volltext
Verfasserangaben:Chao Rong, Yun Liu, Fang Xiang, Xin Zhao, Jinjin Zhang, Zuorun Xiao, Jinsha Wang, Lin Chen, Zhiqi Guo, Ziyu Zhang, Jingnan An, Jing Shen, Jochen Hess, Xiaodong Yuan, Qiong Zhang, and Shouli Wang

MARC

LEADER 00000naa a2200000 c 4500
001 1945736380
003 DE-627
005 20251210121455.0
007 cr uuu---uuuuu
008 251210s2025 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41698-025-01064-8  |2 doi 
035 |a (DE-627)1945736380 
035 |a (DE-599)KXP1945736380 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rong, Chao  |d 1986-  |e VerfasserIn  |0 (DE-588)1127247433  |0 (DE-627)881669199  |0 (DE-576)485140799  |4 aut 
245 1 0 |a Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas  |c Chao Rong, Yun Liu, Fang Xiang, Xin Zhao, Jinjin Zhang, Zuorun Xiao, Jinsha Wang, Lin Chen, Zhiqi Guo, Ziyu Zhang, Jingnan An, Jing Shen, Jochen Hess, Xiaodong Yuan, Qiong Zhang, and Shouli Wang 
264 1 |c 01 August 2025 
300 |b Illustrationen 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.12.2025 
520 |a Soft tissue sarcomas (STS), including rhabdomyosarcoma (RMS), exhibit significant heterogeneity and limited responsiveness to immune checkpoint blockade (ICB). Unsupervised tumor immune phenotype based on multi-omics expression profiling of STS has been less studied. To reveal the tumor immune phenotype of STS and identify promising therapeutic targets, multi-omics expression profiling across various subtypes of STS was investigated. Here, we established a novel molecular classifier based on immune cell subsets related to TGFβ1 and IFNγ to identify distinct immune phenotypes with higher or lower cytotoxic contents. Immune-high clusters demonstrated enriched immune cell infiltration, elevated IFNγ-related signatures, and favorable clinical outcomes. In contrast, immune-low clusters were enriched for immunosuppressive cell types and exhibited poor survival. CHEK1 emerged as a key node associated with immunosuppressive phenotypes and was significantly overexpressed in immune-low tumors. In situ analysis of independent validation cohorts revealed the significant correlation between CHEK1 and tumor-infiltrating immune cells. Collectively, our findings establish a novel risk assessment strategy for RMS and STS patients, and highlight the potential of CHEK1 as a promising therapeutic target in combination with immune checkpoint inhibitor therapy. 
650 4 |a Biomarkers 
650 4 |a Cancer 
650 4 |a Health care 
650 4 |a Medical research 
650 4 |a Molecular medicine 
650 4 |a Oncology 
700 1 |a Liu, Yun  |e VerfasserIn  |4 aut 
700 1 |a Xiang, Fang  |e VerfasserIn  |4 aut 
700 1 |a Zhao, Xin  |e VerfasserIn  |4 aut 
700 1 |a Zhang, Jinjin  |e VerfasserIn  |4 aut 
700 1 |a Xiao, Zuorun  |e VerfasserIn  |4 aut 
700 1 |a Wang, Jinsha  |e VerfasserIn  |4 aut 
700 1 |a Chen, Lin  |e VerfasserIn  |4 aut 
700 1 |a Guo, Zhiqi  |e VerfasserIn  |4 aut 
700 1 |a Zhang, Ziyu  |e VerfasserIn  |4 aut 
700 1 |a An, Jingnan  |e VerfasserIn  |4 aut 
700 1 |a Shen, Jing  |e VerfasserIn  |4 aut 
700 1 |a Heß, Jochen  |d 1971-  |e VerfasserIn  |0 (DE-588)121902390  |0 (DE-627)705696057  |0 (DE-576)292983417  |4 aut 
700 1 |a Yuan, Xiaodong  |e VerfasserIn  |4 aut 
700 1 |a Zhang, Qiong  |e VerfasserIn  |4 aut 
700 1 |a Wang, Shouli  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t npj precision oncology  |d [London] : Springer Nature, 2017  |g 9(2025), Artikel-ID 268, Seite 1-14  |h Online-Ressource  |w (DE-627)884384454  |w (DE-600)2891458-2  |w (DE-576)486547728  |x 2397-768X  |7 nnas  |a Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas 
773 1 8 |g volume:9  |g year:2025  |g elocationid:268  |g pages:1-14  |g extent:14  |a Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas 
856 4 0 |u https://doi.org/10.1038/s41698-025-01064-8  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.nature.com/articles/s41698-025-01064-8  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20251210 
993 |a Article 
994 |a 2025 
998 |g 121902390  |a Heß, Jochen  |m 121902390:Heß, Jochen  |d 910000  |d 911000  |d 50000  |e 910000PH121902390  |e 911000PH121902390  |e 50000PH121902390  |k 0/910000/  |k 1/910000/911000/  |k 0/50000/  |p 13 
999 |a KXP-PPN1945736380  |e 4826086105 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1038/s41698-025-01064-8"],"eki":["1945736380"]},"physDesc":[{"noteIll":"Illustrationen","extent":"14 S."}],"person":[{"family":"Rong","display":"Rong, Chao","given":"Chao","role":"aut"},{"family":"Liu","role":"aut","given":"Yun","display":"Liu, Yun"},{"display":"Xiang, Fang","given":"Fang","role":"aut","family":"Xiang"},{"family":"Zhao","given":"Xin","display":"Zhao, Xin","role":"aut"},{"family":"Zhang","role":"aut","given":"Jinjin","display":"Zhang, Jinjin"},{"family":"Xiao","display":"Xiao, Zuorun","given":"Zuorun","role":"aut"},{"display":"Wang, Jinsha","given":"Jinsha","role":"aut","family":"Wang"},{"role":"aut","given":"Lin","display":"Chen, Lin","family":"Chen"},{"family":"Guo","role":"aut","given":"Zhiqi","display":"Guo, Zhiqi"},{"family":"Zhang","role":"aut","display":"Zhang, Ziyu","given":"Ziyu"},{"display":"An, Jingnan","given":"Jingnan","role":"aut","family":"An"},{"display":"Shen, Jing","given":"Jing","role":"aut","family":"Shen"},{"family":"Heß","role":"aut","display":"Heß, Jochen","given":"Jochen"},{"display":"Yuan, Xiaodong","given":"Xiaodong","role":"aut","family":"Yuan"},{"role":"aut","display":"Zhang, Qiong","given":"Qiong","family":"Zhang"},{"family":"Wang","role":"aut","given":"Shouli","display":"Wang, Shouli"}],"title":[{"title_sort":"Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas","title":"Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Chao Rong, Yun Liu, Fang Xiang, Xin Zhao, Jinjin Zhang, Zuorun Xiao, Jinsha Wang, Lin Chen, Zhiqi Guo, Ziyu Zhang, Jingnan An, Jing Shen, Jochen Hess, Xiaodong Yuan, Qiong Zhang, and Shouli Wang"]},"language":["eng"],"relHost":[{"language":["eng"],"name":{"displayForm":["published by Springer Nature in partnership with The Hormel Institute, University of Minnesota"]},"id":{"issn":["2397-768X"],"zdb":["2891458-2"],"eki":["884384454"]},"pubHistory":["20 March 2017-"],"origin":[{"dateIssuedDisp":"[2017]-","publisher":"Springer Nature","publisherPlace":"[London]"}],"note":["Gesehen am 20. April 2017"],"recId":"884384454","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomasnpj precision oncology","physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"9","extent":"14","year":"2025","pages":"1-14","text":"9(2025), Artikel-ID 268, Seite 1-14"},"title":[{"title":"npj precision oncology","subtitle":"a natureresearch journal","title_sort":"npj precision oncology"}],"titleAlt":[{"title":"a nature research journal"},{"title":"Precision oncology"}]}],"recId":"1945736380","origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"01 August 2025"}],"note":["Gesehen am 10.12.2025"]} 
SRT |a RONGCHAOLIINTEGRATIV0120